Ann Clin Neurophysiol.  2020 Oct;22(2):112-116. 10.14253/acn.2020.22.2.112.

Overlap syndrome of Miller-Fisher syndrome/Pharyngeal-Cervical-Brachial variant-Guillain Barre Syndrome with anti-ganglioside complex antibodies

Affiliations
  • 1Department of Neurology, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
  • 2Neuroimmunology Research Group, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
  • 3Department of Neurology, Kosin University College of Medicine, Busan, Korea
  • 4Department of Neurology, Inje University Haeundae Paik Hospital, Busan, Korea
  • 5Peripheral Neuropathy Research Center, Dong-A University College of Medicine, Busan, Korea
  • 6Department of Neurology, Dong-A University Hospital, Busan, Korea

Abstract

Guillain-Barré syndrome (GBS) and Miller Fisher syndrome (MFS) can present with overlapping features. A 56-year-old female developed ptosis and diplopia after an upper respiratory infection, and presented with facial palsy, dysarthria, brachial weakness, ataxia, and areflexia. Mild weakness of both legs appeared after a few days. Anti-ganglioside complex antibody were positive to IgG GM1/GQ1b and GQ1b/sulfatide antibodies. The present case suggests that the manifestation of overlap between MFS/PCB variants and GBS could be caused by antiganglioside complex antibodies.

Keyword

Guillain-Barré syndrome; Miller Fisher syndrome; Pharyngeal-cervical-brachial variant; Antibodies; Ganglioside; Anti-ganglioside complex

Reference

1. Kim JK, Bae JS, Kim DS, Kusunoki S, Kim JE, Kim JS, et al. Prevalence of anti-ganglioside antibodies and their clinical correlates with guillain-barre syndrome in Korea: a nationwide multicenter study. J Clin Neurol. 2014; 10:94–100.
2. Wakerley BR, Uncini A, Yuki N, the GBS Classification Group. Guillain-Barré and Miller Fisher syndromes--new diagnostic classification. Nat Rev Neurol. 2014; 10:537–544.
Article
3. Kim JK, Kim BJ, Shin HY, Shin KJ, Nam TS, Oh J, et al. Acute bulbar palsy as a variant of Guillain-Barré syndrome. Neurology. 2016; 86:742–747.
Article
4. Nagashima T, Koga M, Odaka M, Hirata K, Yuki N. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. Arch Neurol. 2007; 64:1519–1523.
Article
5. Sekiguchi Y, Mori M, Misawa S, Sawai S, Yuki N, Beppu M, et al. How often and when Fisher syndrome is overlapped by Guillain-Barré syndrome or Bickerstaff brainstem encephalitis? Eur J Neurol. 2016; 23:1058–1063.
Article
6. Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, Hirakawa M, et al. Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann Neurol. 2004; 56:567–571.
Article
7. Huh SY, Lee SY, Lee JH, Lee WG, Kim JK, Yoon BA, et al. A variant Guillain-Barré syndrome with anti-ganglioside complex antibody. J Neurocrit Care. 2018; 11:134–136.
Article
8. Koga M, Yoshino H, Morimatsu M, Yuki N. Anti-GT1a IgG in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2002; 72:767–771.
9. Morikawa M, Kuwahara M, Ueno R, Samukawa M, Hamada Y, Kusunoki S. Serological study using glycoarray for detecting antibodies to glycolipids and glycolipid complexes in immune-mediated neuropathies. J Neuroimmunol. 2016; 301:35–40.
Article
10. Wakerley BR, Yuki N. Polyneuritis cranialis: oculopharyngeal subtype of Guillain-Barré syndrome. J Neurol. 2015; 262:2001–2012.
Article
Full Text Links
  • ACN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr